{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:49:09Z","timestamp":1792705749271,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejmech.2023.116013","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T18:12:29Z","timestamp":1701367949000},"page":"116013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease"],"prefix":"10.1016","volume":"264","author":[{"given":"Shuanghong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jucheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4501-4102","authenticated-orcid":false,"given":"Zeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.116013_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer's disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ejmech.2023.116013_bib2","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.008207","article-title":"The essential elements of Alzheimer's disease","volume":"296","author":"Lei","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2023.116013_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097748","article-title":"Frontier on Alzheimer's disease","volume":"24","author":"Cervellati","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.116013_bib5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JAD-160388","article-title":"Alzheimer's disease: Assessing the role of Spirochetes, Biofilms, the immune system, and amyloid-\u03b2 with regard to potential treatment and prevention","volume":"53","author":"Allen","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2023.116013_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ceb.2003.10.015","article-title":"Mitochondrial fission in apoptosis, neurodegeneration and aging","volume":"15","author":"Bossy-Wetzel","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116013_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/cn500119g","article-title":"Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease","volume":"5","author":"Wang","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.116013_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2023.116013_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-018-0234-4","article-title":"Recent advances in cholinergic imaging and cognitive decline\u2014revisiting the cholinergic hypothesis of dementia","volume":"7","author":"Bohnen","year":"2018","journal-title":"Current Geriatrics Reports"},{"key":"10.1016\/j.ejmech.2023.116013_bib11","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.116013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114689","article-title":"Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease","volume":"242","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib13","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1080\/14756366.2022.2117912","article-title":"A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)","volume":"37","author":"Evangelista","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.ejmech.2023.116013_bib14","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2174\/1389557521666210212151127","article-title":"Multi-target drug design of anti-Alzheimer's disease based on tacrine","volume":"21","author":"Tian","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144337","article-title":"Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.116013_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","article-title":"Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer's disease","volume":"129","author":"Thal","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2023.116013_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejmech.2023.116013_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110887","article-title":"Melatonin regulates A\u03b2 production\/clearance balance and A\u03b2 neurotoxicity: a potential therapeutic molecule for Alzheimer's disease","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.116013_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer's disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2023.116013_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115120","article-title":"Novel neuroprotective pyromeconic acid derivatives with concurrent anti-A\u03b2 deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease","volume":"248","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2023.116013_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer's disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejmech.2023.116013_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","article-title":"Oxidative stress hypothesis in Alzheimer's disease: a reappraisal","volume":"29","author":"Pratic\u00f2","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.116013_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2023.116013_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JAD-2011-100044","article-title":"Novel anti-inflammatory compound SEN1176 alleviates behavioral deficits induced following bilateral intrahippocampal injection of aggregated amyloid-\u03b2\u2081\u208b\u2084\u2082","volume":"25","author":"O'Hare","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2023.116013_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ejmech.2023.116013_bib27","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2023.116013_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2019.05.032","article-title":"Triptolide: medicinal chemistry, chemical biology and clinical progress","volume":"176","author":"Hou","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib29","first-page":"789","article-title":"Synthesis of some new quinazolinone derivatives and evaluation of their antimicrobial activities","volume":"11","author":"Khodarahmi","year":"2012","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmech.2023.116013_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymeth.2014.08.014","article-title":"Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme","volume":"71","author":"Zhong","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.ejmech.2023.116013_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128212","article-title":"Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease","volume":"49","author":"Nerella","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2023.116013_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127659","article-title":"Novel deoxyvasicinone and tetrahydrocarboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation","volume":"30","author":"Du","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.116013_bib33","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1021\/acschemneuro.8b00699","article-title":"Novel deoxyvasicinone-donepezil hybrids as potential multitarget drug candidates for Alzheimer's disease","volume":"10","author":"Du","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.116013_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114956","article-title":"Novel tryptanthrin derivatives with benzenesulfonamide substituents: design, synthesis, and anti-inflammatory evaluation","volume":"246","author":"Du","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib35","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.bmc.2005.01.039","article-title":"Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors","volume":"13","author":"Chen","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108933","article-title":"Synthesis, antimicrobial, and Antibiofilm activities of some novel 7-methoxyquinoline derivatives bearing sulfonamide moiety against Urinary tract infection-causing pathogenic microbes","volume":"24","author":"Ghorab","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.116013_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104237","article-title":"Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents","volume":"104","author":"Hao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib38","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.ejmech.2010.03.014","article-title":"Some new biologically active metal-based sulfonamide","volume":"45","author":"Chohan","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib39","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bmc.2016.01.041","article-title":"Metal-based biologically active azoles and \u03b2-lactams derived from sulfa drugs","volume":"24","author":"Ebrahimi","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib40","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.saa.2007.01.034","article-title":"Synthesis, characterization and thermal studies on metal complexes of new azo compounds derived from sulfa drugs","volume":"68","author":"Mohamed","year":"2007","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2023.116013_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114677","article-title":"Recent advances in \u03b2-lactamase inhibitor chemotypes and inhibition modes","volume":"242","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113566","article-title":"New nimesulide derivatives with amide\/sulfonamide moieties: selective COX-2 inhibition and antitumor effects","volume":"221","author":"G\u00fcng\u00f6r","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105424","article-title":"Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives","volume":"117","author":"Abdel-Maksoud","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejmech.2017.09.008","article-title":"Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation","volume":"140","author":"Ma","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib45","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2174\/1389557521666211027104638","article-title":"A review on the in vitro evaluation of the Anticholinesterase activity based on ellman's method","volume":"22","author":"de Almeida","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113124","article-title":"Design, synthesis and biological evaluation of new benzoxazolone\/benzothiazolone derivatives as multi-target agents against Alzheimer's disease","volume":"212","author":"Erdogan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2015.01.004","article-title":"A newly designed molecule J2326 for Alzheimer's disease disaggregates amyloid fibrils and induces neurite outgrowth","volume":"92","author":"Chang","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2023.116013_bib48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ejmech.2018.01.014","article-title":"Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment","volume":"145","author":"Czarnecka","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2016.12.045","article-title":"Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, A\u03b2(1-42) aggregation inhibitors and metal-chelating agents for Alzheimer's disease","volume":"127","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.116013_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.fct.2016.12.008","article-title":"Molecular evidence on the protective effect of ellagic acid on phosalone-induced senescence in rat embryonic fibroblast cells","volume":"100","author":"Baeeri","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2023.116013_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2023.116013_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114497","article-title":"Novel quinoline-based derivatives: a new class of PDE4B inhibitors for adjuvant-induced arthritis","volume":"238","author":"Xing","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105037","article-title":"Synthesis and evaluation of the anti-inflammatory activity of novel 8-quinolinesulfonamide derivatives as TLR4\/MD-2 inhibitors with efficacy in adjuvant-induced arthritis","volume":"114","author":"Liu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib55","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.116013_bib56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib57","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.21580","article-title":"Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB","volume":"98","author":"Di","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejmech.2023.116013_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113112","article-title":"2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease","volume":"211","author":"Mezeiova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113973","article-title":"Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease","volume":"227","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116013_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109350","article-title":"Biological evaluation of 7-O-amide hesperetin derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"334","author":"Wu","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.116013_bib61","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb400080f","article-title":"Untangling amyloid-\u03b2, tau, and metals in Alzheimer's disease","volume":"8","author":"Savelieff","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2023.116013_bib62","first-page":"S277","article-title":"The metal theory of Alzheimer's disease","volume":"33","author":"Bush","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2023.116013_bib63","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12906-019-2735-x","article-title":"Heracleum moellendorffii roots inhibit the production of pro-inflammatory mediators through the inhibition of NF-\u03baB and MAPK signaling, and activation of ROS\/Nrf2\/HO-1 signaling in LPS-stimulated RAW264.7 cells","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Complement Altern Med"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:58:48Z","timestamp":1759330728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423009807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":63,"alternative-id":["S0223523423009807"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116013","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116013"}}